Tambwe willy Muzumbukilwa | Health Professions | Best Researcher Award

Dr. Tambwe willy Muzumbukilwa | Health Professions | Best Researcher Award

Healthcare Quality Management, HIV and AIDS at University of Kwazulu-Natal, South Africa

Dr. Tambwe Willy Muzumbukilwa is a distinguished Ph.D. candidate in pharmacology at the University of KwaZulu-Natal, South Africa, with a research focus on healthcare quality management. His primary interest is in enhancing clinical performance and care delivery for individuals living with HIV/AIDS. He holds an MBChB from Université Évangélique en Afrique in the Democratic Republic of Congo and an MSc in Pharmacology from the University of KwaZulu-Natal. As a medical doctor with extensive experience in public health and hospital management, Dr. Muzumbukilwa has demonstrated a commitment to improving healthcare outcomes for vulnerable populations. His leadership roles in various healthcare institutions in the Democratic Republic of Congo, combined with his research on quality indicators for clinical care, have solidified his reputation as a dedicated researcher and practitioner. Dr. Muzumbukilwa is also proficient in laboratory research, focusing on the pharmacological activities of medicinal plants, and has a strong publication record in reputable journals.

Professional Profile

Education

Dr. Muzumbukilwa’s academic journey began with a Bachelor of Medicine and Surgery (MBChB) from Université Évangélique en Afrique, Democratic Republic of Congo. He later pursued a Master of Pharmacology at the University of KwaZulu-Natal, South Africa, where he specialized in the pharmacological properties of medicinal plants. Currently, he is completing his Ph.D. in Pharmacology at the same institution. His doctoral research focuses on healthcare quality management, specifically on developing and evaluating HIV clinical care quality indicators. Dr. Muzumbukilwa’s academic background reflects his dedication to combining clinical expertise with advanced research to address critical healthcare challenges.

Professional Experience

Dr. Muzumbukilwa has held several impactful roles in healthcare management and research. His professional career began with internships at Panzi General Hospital and Lemera General Hospital in the DRC. He later served as a District Health Manager in Minembwe and as a Clinical Manager at Kitutu General Hospital. Additionally, he worked as a Medical Officer at Baraka and Itombwe Hospitals. Since 2017, he has been a researcher at the University of KwaZulu-Natal, focusing on healthcare quality management for individuals living with HIV/AIDS and the hepatoprotective effects of medicinal plants. His extensive experience in leadership and clinical management highlights his ability to address complex public health issues.

Research Interests

Dr. Muzumbukilwa’s research interests center on healthcare quality management and the improvement of clinical care for HIV/AIDS patients. He focuses on developing quality indicators to assess clinical performance and improve health outcomes. His work also extends to laboratory research, particularly the pharmacological activity of medicinal plants in vivo. His interdisciplinary approach bridges clinical and pharmacological research, enabling him to address public health challenges comprehensively.

Research Skills

Dr. Muzumbukilwa possesses a wide range of research skills, including developing and evaluating quality indicators for healthcare performance, conducting systematic reviews, and assessing treatment outcomes. His expertise extends to laboratory techniques, such as pharmacological testing of medicinal plants and animal models for diabetes research. His ability to combine clinical insights with advanced research methodologies has been instrumental in his contributions to healthcare quality improvement.

Awards and Honors

Dr. Muzumbukilwa has been recognized for his academic and research achievements. He received the CHS Scholarship for his postgraduate studies at the University of KwaZulu-Natal in 2018 and 2019, which supported his research on healthcare quality management. Additionally, his work has been widely published in reputable journals, further underscoring his contributions to the fields of pharmacology and public health.

Conclusion

Dr. Tambwe Willy Muzumbukilwa’s combination of academic excellence, professional experience, and innovative research makes him a strong candidate for the Best Researcher Award. His dedication to improving healthcare outcomes for vulnerable populations, particularly those living with HIV/AIDS, and his significant contributions to pharmacological research highlight his impact in the field. With his leadership skills, extensive research background, and commitment to advancing public health, Dr. Muzumbukilwa exemplifies the qualities of an outstanding researcher and healthcare professional.

Publication Top Notes

  1. Developing HIV indicators for clinical care quality assessment: relevance and practicality evaluated by healthcare practitioners in South Africa and Democratic Republic of Congo
    • Authors: Muzumbukilwa, T.W., Manimani, R.G., Vagiri, R.V., Bihehe, M.D., Mushebenge, A.G.A.
    • Journal: BMJ Open Quality
    • Year: 2024
  2. Evaluating compliance with quality indicators of HIV and AIDS clinical care and analyzing those associated with mortality in the Democratic Republic of Congo
    • Authors: Muzumbukilwa, T.W., Dieudonne, B.M., Manimani, R.G., Vagiri, R.V., Nlooto, M.
    • Journal: BMC Infectious Diseases
    • Year: 2024
  3. Assessing the pertinence and usefulness of HIV and AIDS indicators for evaluating clinical care quality: Perspectives of health care professionals
    • Authors: Muzumbukilwa, T.W., Riziki Ghislain, M., Mushebenge, A.G.-A., Vagiri, R.V., Nlooto, M.
    • Journal: African Journal of AIDS Research
    • Year: 2024
  4. Development of a Fundamental Set of Quality Indicators for Evaluating HIV and AIDS Clinical Care: A Systematic Review
    • Authors: Muzumbukilwa, T.W., Ghislain, M.R., Pascal, E.M., Vagiri, R.V., Nlooto, M.
    • Journal: Universal Journal of Public Health
    • Year: 2023
    • Citations: 3
  5. Risk factors for death in hospitalized COVID-19 patients in Africa: A systematic review and meta-analysis
    • Authors: Riziki Ghislain, M., Muzumbukilwa, W.T., Magula, N.
    • Journal: Medicine (United States)
    • Year: 2023
    • Citations: 3
  6. Mapping the evidence of hepatoprotective properties of Moringa oleifera from sub-Saharan African countries: A systematic review protocol
    • Authors: Muzumbukilwa, W.T., Kadima, M.G., Nlooto, M., Owira, P.M.O.
    • Journal: Systematic Reviews
    • Year: 2019
    • Citations: 7
  7. Hepatoprotective effects of Moringa oleifera Lam (Moringaceae) leaf extracts in streptozotocin-induced diabetes in rats
    • Authors: Muzumbukilwa, W.T., Nlooto, M., Owira, P.M.O.
    • Journal: Journal of Functional Foods
    • Year: 2019
    • Citations: 25

 

 

 

Kaleab Tegegne | Health Professions | Best Researcher Award

Mr. Kaleab Tegegne | Health Professions | Best Researcher Award

Researcher at Debark University, Ethiopia

Kaleab Tesfaye Tegegne is a dedicated researcher and educator in the field of public health, currently serving as a Lecturer and Researcher at Debark University in Ethiopia. With a focus on epidemiology, maternal and child health, and public health research, Tegegne has significantly contributed to both academia and public health practice. He has established a solid reputation through his impactful research, leading to publications in prominent journals and securing funding for critical research initiatives. His experience spans across multiple prestigious institutions, including Hawassa College of Health Science and Debark University, where he has both taught and mentored students in public health programs. Tegegne’s academic and professional experiences are complemented by his leadership in research projects that aim to improve public health conditions in Ethiopia. His work on cerebral palsy, maternal health, and anemia showcases his ability to address pressing health challenges and make a meaningful impact on public health policies in the region.

Professional Profile

Education

Kaleab Tesfaye Tegegne’s educational background is marked by excellence and commitment to the field of public health. He holds a Master of Public Health (MPH) degree from the University of Gondar, Ethiopia, where he achieved a CGPA of 3.53. His academic journey began with a Bachelor of Science (BSc) in Public Health from Haramaya University, Ethiopia, where he earned a CGPA of 3.76. These strong academic achievements laid a solid foundation for his career in public health research and teaching. His education not only provided him with essential knowledge in epidemiology and public health but also nurtured his passion for contributing to the improvement of health systems and public health outcomes, particularly in the context of Ethiopia. Through both his education and extensive practical experience, Tegegne has developed a deep understanding of the critical health issues facing communities, which has fueled his dedication to research and public health interventions aimed at addressing these challenges.

Professional Experience

Tegegne has accumulated valuable professional experience in both academic and research settings. As a Lecturer and Researcher at Debark University since 2022, he has made significant contributions to public health education, teaching courses on epidemiology, research methodology, biostatistics, and nutrition. His role involves not only lecturing but also developing curricula and teaching materials to enhance the academic experience of students. Prior to this, Tegegne served at Hawassa College of Health Science for seven years, where he gained experience supervising undergraduate research projects, many of which were published in reputable journals. His professional journey also includes leadership in research, with several published studies focused on child health, maternal health, and epidemiology. Tegegne’s expertise extends to the successful application for competitive grants, including funding from the Global LMIC CP Register project. His professional experience has solidified his role as an influential figure in Ethiopia’s public health landscape, where his research and teaching are making a tangible difference in improving community health outcomes.

Research Interests

Tegegne’s research interests center around public health epidemiology, with a particular focus on child and maternal health. He has conducted significant research on topics such as the prevalence of anemia in women and children, the epidemiology of cerebral palsy, and the psychosocial impact of health conditions on affected families. His research is driven by a desire to understand the factors contributing to health disparities and to develop interventions that improve health outcomes, particularly in low-resource settings. Tegegne is particularly focused on issues affecting vulnerable populations, including children, pregnant women, and underserved communities in Ethiopia. His research interests also extend to broader epidemiological studies, where he aims to identify determinants of health conditions, evaluate public health programs, and inform health policies that can drive positive change in Ethiopia and similar contexts. His extensive body of work reflects his commitment to tackling some of the most pressing public health challenges facing developing countries today.

Research Skills

Tegegne possesses a diverse skill set that enhances his ability to conduct impactful public health research. He is proficient in a range of statistical and research software tools, including SPSS, STATA, Revman, Epi Info, EpiData, ArcGIS, and SaTscan. These tools are integral to his expertise in statistical modeling, data analysis, and spatial analysis, which he applies to examine public health data and identify trends and patterns. His skills in using advanced software for statistical modeling have been key in his research on epidemiology, as well as his work on health outcomes such as anemia and cerebral palsy. Additionally, Tegegne has a deep understanding of research methodology, including systematic reviews and meta-analyses, which he employs to synthesize findings from various studies. His research expertise is complemented by his ability to mentor and supervise students in research, equipping them with the skills to conduct their own research projects. Tegegne’s proficiency in both qualitative and quantitative research methods ensures that his work is rigorous, relevant, and impactful.

Awards and Honors

Throughout his academic and professional career, Kaleab Tesfaye Tegegne has received several prestigious awards and honors. Among these is a research grant from the Global LMIC CP Register project, which supports his work on cerebral palsy in Ethiopia. This award highlights the significance of his research in addressing important health challenges and improving care for affected children. Tegegne has also received competitive grants from Debark University to investigate factors related to cerebral palsy and the psychosocial impacts on parents. These awards reflect the recognition of his work by esteemed organizations and institutions. Additionally, his numerous publications in respected journals, including Scopus- and PubMed-indexed articles, have contributed to his academic reputation. His research leadership and commitment to public health have earned him recognition both in Ethiopia and internationally. These honors and awards attest to his dedication to advancing public health knowledge and improving the lives of vulnerable populations.

Conclusion

Kaleab Tesfaye Tegegne is an exemplary candidate for the Academic Research Impact Award due to his significant contributions to public health research and education. His academic achievements, including a strong educational background and numerous high-impact publications, showcase his expertise in epidemiology and public health. Tegegne’s professional experience, particularly his leadership in research and curriculum development, further strengthens his qualifications. His research interests, focusing on child and maternal health, are both timely and crucial, addressing health issues that impact vulnerable populations in Ethiopia. The awards and honors he has received reflect the recognition of his work on national and international levels. While there are opportunities for growth in expanding his research focus and building international collaborations, Tegegne’s body of work speaks to his passion for advancing public health, and his continued contributions will undoubtedly have a lasting impact on the field. His dedication to improving health outcomes in Ethiopia, particularly through his groundbreaking work on cerebral palsy, positions him as a leader in public health research.

Publication Top Notes

  • Title: Associations between prior abortion and hepatitis B virus infection among pregnant women attending health care facilities. Meta-analysis
    Authors: Kaleab Tesfaye Tegegne, Tadele Kassahun Wudu, Abebe Tadesse Tibebu, Eleni Tesfaye Tegegne, Mekibib Kassa Tessema
    Year: 2024
    DOI: 10.1186/s40001-024-02090-1
  • Title: Spatial distribution and determinant factors of anemia among women age 15-49 years in Burkina Faso; using mixed-effects ordinal logistic regression model
    Authors: Kaleab Tesfaye Tegegne, Eleni Tesfaye Tegegne, Mekibib Kassa Tessema, Tadele Kassahun Wudu, Moges Tadesse Abebe, Asmamaw Workineh Zegeye
    Year: 2024
    DOI: 10.15167/2421-4248/JPMH2024.65.2.3227
  • Title: Factors associated with clinical practice competency among nursing and health science students in Ethiopia
    Authors: Kaleab Tesfaye Tegegne, Jemberu Chane Fetene, Tadele Kassahun Wudu, Yosef Aragaw Gonete, Abebe Tadesse Tibebu, Yideg Abinew, Moges Tadesse Abebe
    Year: 2024
    DOI: 10.15566/cjgh.v11i1.787
  • Title: Knowledge, Attitude, Practice, and Associated Factors of Implant Use in Women, Ethiopia
    Authors: Kaleab Tesfaye Tegegne, Girma Teferi, Tadele Kassahun Wudu, Yideg Abinew, Eleni Tesfaye Tegegne, Mekibib Kassa Tessema, Carlos M. Ardila
    Year: 2024
    DOI: 10.1155/2024/9978336
  • Title: Prevalence and Associated Factors of Anemia Among Pregnant Women Attending Antenatal Care at Mizan Aman General Hospital, Bench Maji Zone, Southwest, Ethiopia
    Authors: Kaleab Tesfaye Tegegne, Seblework Abeje, Eleni Tesfaye Tegegne, Mekibib Kassa Tessema, Tadele Kassahun Wudu, Mihnea-Alexandru Gaman
    Year: 2024
    DOI: 10.1155/anem/2655891
  • Title: Determinants of cerebral palsy in children: systematic review
    Authors: Kaleab Tegegne
    Year: 2023
    DOI: 10.24911/sjp.106-1670589241
  • Title: Institutional delivery knowledge, attitude, and practice among mothers of childbearing age with one or more children, Ethiopia
    Authors: Tegegne, K.T.; Wudu, T.K.; Abdisa, B.G.; Tegegne, E.T.; Tessema, M.K.
    Year: 2023
    DOI: 10.15167/2421-4248/jpmh2023.64.1.2864
  • Title: Knowledge and utilization of screening for cervical cancer among female in Ethiopia: a systemic review and meta-analysis
    Authors: T. T. Kaleab, T. T. Eleni, A. A. Abiyu, K. T. Mekibib
    Year: 2021
    DOI: 10.32113/wcrj_20211_1844
  • Title: Prevalence of Road Traffic Accidents and Associated Factors in Chuko Town, Southern Ethiopia, 2017
    Authors: Tegegne, K.T.
    Year: 2020
    DOI: 10.29252/johe.9.2.76
  • Title: Erratum: Consistent Condom Use and Associated Factors among HIV-Positive Clients on Antiretroviral Therapy in North West Ethiopian Health Center, 2016 GC (AIDS Research and Treatment (2019) 2019 (7134908) DOI: 10.1155/2019/7134908)
    Authors: Seid Ali, M.; Tesfaye Tegegne, E.; Kassa Tessema, M.; Tesfaye Tegegne, K.
    Year: 2019
    DOI: 10.1155/2019/8218107

 

Minji Jung | Health Professions | Best Researcher Award

Dr. Minji Jung | Health Professions | Best Researcher Award

Postdoctoral Scholar at Stanford University Medical Center, United States

Minji Jung is a prominent researcher with expertise in cancer epidemiology, pharmacoepidemiology, and risk factors for chronic diseases such as kidney cancer and cardiovascular conditions. She currently serves as a Postdoctoral Scholar at the Urologic Cancer Epidemiology Lab at Stanford University School of Medicine. Minji has an extensive academic background, earning a PhD in Clinical Pharmacoepidemiology and holding a PharmD degree from Ajou University, South Korea. Her research has spanned multiple high-impact areas, including kidney cancer, cardiovascular diseases, and dementia, with a focus on real-world data analysis. Minji has secured significant research funding, led interdisciplinary projects, and earned numerous awards, underscoring her substantial contributions to health sciences. Her work integrates diverse data sets, cutting-edge statistical methods, and collaborative partnerships, making her a leading figure in her field.

Professional Profile

Education:

Minji Jung holds a PharmD from Ajou University in South Korea, completed in 2016, where she also earned her PhD in Clinical Pharmacoepidemiology in 2021. During her doctoral studies, Minji focused on evaluating the pleiotropic effects of statin therapy, specifically investigating its potential role in preventing hemorrhagic stroke and dementia using Korean nationwide health insurance data. She has further honed her expertise as a Research Fellow at the University of California, San Francisco, in 2021-2022, specializing in pharmacoepidemiology related to cardiovascular disease. Minji’s education has been marked by a strong foundation in clinical pharmacy, epidemiology, and data analytics, laying the groundwork for her current focus on urologic cancer and cardio-oncology research.

Professional Experience:

Minji Jung’s professional journey includes roles in academia and research, where she has made significant strides in clinical pharmacy and epidemiology. She is currently a Postdoctoral Scholar at Stanford University’s Urologic Cancer Epidemiology Lab, where she focuses on cancer epidemiology, pharmacoepidemiology, and kidney cancer research. Previously, she served as a Research Fellow at the University of California, San Francisco, contributing to studies on cardiovascular disease and medication adherence. Minji’s early research experience includes working at Ajou University, South Korea, where she contributed to pharmacoepidemiological projects examining the effects of statin use and its association with stroke and dementia. Her expertise spans across both clinical and epidemiological settings, enabling her to integrate real-world data into her research and offering valuable insights into chronic disease prevention and management.

Research Interests:

Minji Jung’s research interests are centered on cancer epidemiology, pharmacoepidemiology, and the intersection of chronic diseases such as kidney cancer, cardiovascular conditions, and dementia. Her work focuses on understanding the epidemiology and risk factors associated with kidney cancer, analyzing large health data sets to explore connections between metabolic syndrome and cancer incidence. Additionally, Minji is deeply invested in survivorship and psycho-oncology, exploring the mental and physical health outcomes of patients diagnosed with cancer. Her research also delves into cardio-oncology, investigating the cardiovascular risks of cancer patients, especially those undergoing treatment. By using advanced statistical methods and diverse global data sets, Minji aims to improve the prevention, diagnosis, and treatment of chronic diseases, with a focus on kidney cancer and its broader implications for public health.

Research Skills:

Minji Jung possesses advanced research skills, particularly in epidemiological methods, pharmacoepidemiology, and statistical analysis. She is adept at handling large, diverse data sets, such as SEER, UK Biobank, and MarketScan® data, and has expertise in applying a variety of statistical techniques, including logistic regression, survival analysis, propensity score matching, and Cox regression models. Minji is skilled in utilizing real-world data to study the epidemiology of chronic diseases and their interactions with medications. Her proficiency in data analysis is complemented by her ability to integrate findings from multiple disciplines, allowing her to draw meaningful conclusions that influence clinical and public health policies. Minji is also experienced in project management, having led her own research initiatives, and is well-versed in the application of innovative research methods to investigate complex health issues.

Awards and Honors:

Minji Jung has received numerous awards in recognition of her exceptional research contributions. Notably, she was honored with the Poster Award from the Western Section of the American Urological Association in 2024 and was selected as a Notable Scientist by the Korean Biological Research Information Center in 2023. She also won the Oral Presentation Award at the 24th Annual Spring Research Seminar at the University of California, San Francisco, in 2022. Minji’s achievements are further highlighted by an Oral Presentation Award from the Pharmaceutical Society of Korea in 2019, as well as a Certificate of Commendation from the Suwon Pharmaceutical Association in 2018. These accolades reflect the high regard in which she is held by the scientific community, emphasizing her impactful research in the fields of epidemiology and pharmacoepidemiology.

Conclusion

Minji Jung has demonstrated exceptional research capabilities in areas that have profound implications for public health, particularly in cancer epidemiology and pharmacoepidemiology. Her leadership in securing research grants and contributing to significant health-related findings sets her apart as a candidate for the Best Researcher Award. While there are areas that could be further strengthened, particularly in terms of broadening her influence in the public sphere and maximizing publication impact, her accomplishments thus far make her a highly deserving nominee for the award.

Publication Top Notes

  • Effects of statin therapy on the risk of intracerebral hemorrhage in Korean patients with hyperlipidemia
    Authors: M Jung, S Lee
    Year: 2019
    Citations: 22
  • Impact of statin use on dementia incidence in elderly men and women with ischemic heart disease
    Authors: MY Kim, M Jung, Y Noh, S Shin, CH Hong, S Lee, YS Jung
    Year: 2020
    Citations: 18
  • Efficacy of aspirin in the primary prevention of cardiovascular diseases and cancer in the elderly: a population-based cohort study in Korea
    Authors: M Jung, S Lee
    Year: 2020
    Citations: 10
  • Design and evaluation of in vivo bioavailability in beagle dogs of bilayer tablet consisting of immediate release nanosuspension and sustained release layers of rebamipide
    Authors: G Jin, HV Ngo, J Wang, JH Cui, QR Cao, C Park, M Jung, BJ Lee
    Year: 2022
    Citations: 8
  • Comprehensive trends and patterns of antihypertensive prescriptions using a nationwide claims database in Korea
    Authors: M Jung, E Choo, S Lee
    Year: 2020
    Citations: 7
  • Comparing the sensitivities of measures of adherence to antihypertensive drugs using Korean National Health Insurance Claims Data
    Authors: E Choo, M Jung, J Shin, S Lee
    Year: 2021
    Citations: 5
  • Clinical pharmacokinetic study of tacrolimus in continuous intravenous administration for lung transplantation
    Authors: YM Sohn, RE Ko, HJ Park, E Choo, M Jung, S Lee, K Jeon
    Year: 2023
    Citations: 1
  • A comparison of methods for the measurement of adherence to antihypertensive multidrug therapy and the clinical consequences: a retrospective cohort study using the Korean National Health Insurance Claims Data
    Authors: M Jung, E Choo, S Lee
    Year: 2023
    Citations: 1
  • Effects of Postprandial Factors and Second Meal Intake Time on Bioequivalence Investigation of Tadalafil-Loaded Orodispersible Films in Human Volunteers
    Authors: SJ Park, MC Gil, BS Lee, M Jung, BJ Lee
    Year: 2024
    Citations: Not listed yet
  • Air pollution mixture associated with oxidative stress exacerbation and symptoms deterioration in allergic rhinitis patients: Evidence from a panel study
    Authors: J Li, H Wu, W Xing, X Li, Z Han, R Ji, Z Deng, M Jung, S Sun, BI Chung, …
    Year: 2024